Digital Health Global

JANUARY 10, 2024

LAUSANNE, Switzerland & SAN DIEGO–(BUSINESS WIRE)–Debiopharm, an independent biopharmaceutical company headquartered in Switzerland, and ThinkingNodeLife.ai (TNL), a trailblazer in AI Digital Cells Lab in USA, are pleased to announce a collaborative partnership aimed at advancing the development of a cutting-edge cancer drug.

Drug Development 88

Drug Development Pharmaceuticals Digital Health 88

Digital Health Global

APRIL 5, 2024

DUBLIN–(BUSINESS WIRE)–The “Growth Opportunities in Drug Discovery and Early Development Outsourcing Services” report has been added to ResearchAndMarkets.com’s offering. hike over 2022, with more than 6,100 molecules in active development. growth between 2023 to 2024.

Drug Development 88

Drug Development Pharmaceuticals Digital Health Health Technology 88

Digital Health Global

JANUARY 8, 2024

Top-10 global pharmaceutical companies are already benefiting from Medable’s novel technology, shaving weeks off build times. In 2024, expect to see more innovative technologies and new ways of delivering streamlined, patient-centric trials from Medable.” Medable, which ranked in the top 8% of software companies on the 2023 Inc.

Life Science 88

Life Science Drug Development Pharmaceuticals HIPAA 88

Lloyd Price

FEBRUARY 18, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

Pharmaceuticals 60

Pharmaceuticals healthcare technology Leadership Drug Development 60